Featured news in The Life Sciences Report
|
|
|
Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX)
MESO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Mesoblast Limited Investors of Class Action and Lead Plaintiff Deadline: December 7, 2020 (10/23/2020)
|
|
view 
|
|
|
|
Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX)
DEADLINE ALERT for MESO and RCL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders (10/23/2020)
|
|
view
|
|
|
|
Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX)
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Reminds Mesoblast Limited Investors of Important December 7 Deadline in Securities Class Action - MESO (10/23/2020)
|
|
view
|
|
|
|
|
|
ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences Announces Up to $3 Million Private Placement Offering of Special Warrants (10/23/2020)
|
|
view
|
|
|
|
|
|
Sproutly Canada Inc. (SPR:CSE; SRUTF:OTCQB)
The StockTalk Cannabis Report: Oct. 23, 2020 (10/23/2020)
|
|
view
|
|
|
|
|
|
Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX)
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Mesoblast Limited (MESO) (10/22/2020)
|
|
view
|
|
|
|
Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX)
ROSEN, A TOP RANKED LAW FIRM, Reminds Mesoblast Limited Investors of Important December 7 Deadline in Securities Class Action - MESO (10/22/2020)
|
|
view
|
|
|
|
Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX)
MESO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Mesoblast Limited Investors of Class Action and Lead Plaintiff Deadline: December 7, 2020 (10/22/2020)
|
|
view
|
|
|
|
Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX)
MESO LOSS NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Mesoblast Limited Investors to Contact Firm Before Important December 7 Deadline in Securities Class Action - MESO (10/21/2020)
|
|
view
|
|
|
|
Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mesoblast, Loop Industries, Turquoise Hill Resources, and Reata Pharmaceuticals and Encourages Investors to Contact the Firm (10/21/2020)
|
|
view
|
|
|
|
Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX)
CytoDyn Appoints Mahboob Rahman, M.D., Ph.D., as Chief Scientific Officer (10/21/2020)
|
|
view
|
|
|
|
Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX)
Randomized Controlled Study Using Direct Injection of Remestemcel-L Into Inflamed Gut of Patients With Crohn's Disease and Ulcerative Colitis (10/22/2020)
|
|
view
|
|
|
|
|
|
BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
Catalent and BrainStorm Cell Therapeutics Announce Partnership for the Manufacture of Mesenchymal Stem Cell Platform Therapy NurOwn® (10/22/2020)
|
|
view
|
